Hexamethylmelamine as a single second-line agent in ovarian cancer
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (1) , 93-96
- https://doi.org/10.1016/0090-8258(90)90115-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapyGynecologic Oncology, 1987
- 2ND-LINE CHEMOTHERAPY OF STAGE-III-IV OVARIAN-CARCINOMA - A RANDOMIZED COMPARISON OF MELPHALAN TO MELPHALAN AND HEXAMETHYLMELAMINE IN PATIENTS WITH PERSISTENT DISEASE AFTER DOXORUBICIN AND CISPLATIN1987
- Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1979
- HEXAMETHYLMELAMINE IN OVARIAN-CANCER RESISTANT TO CYCLOPHOSPHAMIDE AND ADRIAMYCIN1979
- PHASE-II TRIAL OF HEXAMETHYLMELAMINE IN OVARIAN-CARCINOMA RESISTANT TO ALKYLATING-AGENTS1979
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958